Loading…
Lobbying Spend
—
Filings
22
Firms Hired
2
Active Period
1999–2008
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Alzheimer's Treatment and Caregiver Support Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1032
S.1145, the Patent Reform Act of 2007
Client expense: — · Firm income: $50,000
Matched citations: S.1145
Preserve Access to Affordable Generics Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
S.316, Preserve Access to Affordable Biologics
Client expense: — · Firm income: $50,000
Matched citations: S.316
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $50,000
Matched citations: S.623
Alzheimer's Treatment and Caregiver Support Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1032
S.1145, the Patent Reform Act of 2007
Client expense: — · Firm income: $30,000
Matched citations: S.1145
Preserve Access to Affordable Generics Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
S.316, Preserve Access to Affordable Biologics
Client expense: — · Firm income: $30,000
Matched citations: S.316
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $30,000
Matched citations: S.623
Alzheimer's Treatment and Caregiver Support Act
2008 · third_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1032
S.1145, the Patent Reform Act of 2007
Client expense: — · Firm income: $40,000
Matched citations: S.1145
Preserve Access to Affordable Generics Act
2008 · third_quarter · Firm: KEVIN MCGUINESS PLLC
S.316, Preserve Access to Affordable Biologics
Client expense: — · Firm income: $40,000
Matched citations: S.316
Access to Life-Saving Medicine Act
2008 · third_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $40,000
Matched citations: S.623
Alzheimer's Treatment and Caregiver Support Act
2008 · second_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1032
S.1145, the Patent Reform Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S.1145
Preserve Access to Affordable Generics Act
2008 · second_quarter · Firm: KEVIN MCGUINESS PLLC
S.316, Preserve Access to Affordable Biologics
Client expense: — · Firm income: $20,000
Matched citations: S.316
Access to Life-Saving Medicine Act
2008 · second_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $20,000
Matched citations: S.623
Alzheimer's Treatment and Caregiver Support Act
2008 · first_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.
Client expense: — · Firm income: $40,000
Matched citations: HR 1032
S. 1145/HR 1908: Patent Reform Act of 2007
Client expense: — · Firm income: $40,000
Matched citations: HR 1908
Reasonable Rates for Veterans Act
2008 · first_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.
Client expense: — · Firm income: $40,000
Matched citations: HR 2795
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 3818
S. 1145/HR 1908: Patent Reform Act of 2007
Client expense: — · Firm income: $40,000
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · first_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 316
Access to Life-Saving Medicine Act
2008 · first_quarter · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 623
Alzheimer's Treatment and Caregiver Support Act
2007 · year_end · Firm: KEVIN MCGUINESS PLLC
Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act
Client expense: — · Firm income: $60,000
Matched citations: HR 1032
S. 1145/HR 1908: Patent Reform Act of 2007
Client expense: — · Firm income: $60,000
Matched citations: HR 1908
Source: Senate LDA